ESC Congress 2013

31 August - 04 September 2013, Amsterdam - The Netherlands

Session Details

Poster Session 5: Atrial fibrillation
Mon 02 Sep 14:00 - 18:00 Atrial fibrillation (AF) Poster Session Posters - Village 9

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:00P4060The impact of new onset atrial fibrillation on mid-term cardiac mortality in patients with acute myocardial infarction.Itsuro MORISHIMA (Ogaki, JP)
14:00P4061Identification of left atrium ganglionated plexi by dense epicardial mapping as ablation targets for the treatment of concomitant atrial fibrillationYusuke KONDO (Bonn, DE)
14:00P4062Real life results of ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Outcome from the German Ablation registry.Marc SCHLOESSER (Bielefeld, DE)
14:00P4063Copeptin levels are associated with cardiovascular events in patients with non valvular atrial fibrillation.Sylvie LANG (Paris Cedex 12, FR)
14:00P4064Improving atrial fibrillation detection and stroke prevention capability by a WEB-based application. A multicenter Italian research on AFinder application.Alessandro PROCLEMER (Udine, IT)
14:00P4065Twelve-month outcomes in paroxysmal versus permanent atrial fibrillation: data from the prospective, international GARFIELD registryAlexander TURPIE (Dundas, CA)
14:00P4066Plasma mid-regional pro-atrial natriuretic peptide is associated with and improves prediction of lone atrial fibrillationIan Cheng-Yi CHANG (Eagan, US)
14:00P4067Carotid intima-media thickness, carotid distensibility, and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA)Lin Yee CHEN (North Oaks, US)
14:00P4068Atrial fibrillation detection algorithms alone are inadequate for identifying atrial arrhythmia by implantable loop recorder after ischaemic stroke.Darshan BRAHMBHATT (Cambridge, GB)
14:00P4069(W)How important is the atrial fibrillation classification? Incidence of stroke in atrial fibrillation: report from the Montevideo-CASMU Cohort of atrial fibrillation 
14:00P4070Association between silent atrial fibrillation and heart failure after acute myocardial infarctionKarim STAMBOUL (Dijon, FR)
14:00P4071The association between hyperuricemia, left atrial size and new-onset atrial fibrillationTze-Fan CHAO (Taipei, TW)
14:00P4072The natural history of atrial fibrillation after the first documented episode. Different evolution of persistent and non-persistent atrial fibrillation.Ariana GONZALEZ GOMEZ (Madrid, ES)
14:00P4073Silent brain ischemic lesions detected on magnetic resonance imaging in patients undergoing catheter ablation of atrial fibrillation.Marek SRAMKO (Prague, CZ)
14:00P4074Electrophysiological correlation and prognostic impact of pentraxin 3 as a local inflammatory marker in atrial fibrillationTakeshi SOEKI (Tokushima, JP)
14:00P4075Runs of premature atrial complexes predict increased mortality in patients with ischemic stroke and sinus rhythmKristina Hoeg VINTHER (Odense Sv, DK)
14:00P4076Inflammatory bowel disease increases the risk of atrial fibrillation, particularly during active disease stages. a nationwide cohort studySoeren Lund KRISTENSEN (Hellerup, DK)
14:00P4077Statins reduce the incidence of dementia in patients with atrial fibrillation: a nationwide cohort study.Min-Tsun LIAO (Hsinchu, TW)
14:00P4078Relationship between CHA2DS2-VASc score and prophylactic efficacy during antiarrhythmic drugs therapy in patients with paroxysmal atrial fibrillation. Hironobu UEDA (Morioka, JP)
14:00P4079Diabetes is associated with doubling in risk of atrial fibrillation compared to the background population a nationwide studyJannik PALLISGAARD (Hellerup, DK)
14:00P4080Is atrial fibrillation associated with a decrease in total brain perfusion?Marianna GARDARSDOTTIR (Reykjavik, IS)
14:00P4081Incidence and risk of atrial fibrillation in sleep apnea patients without coexistent systemic diseasesTze-Fan CHAO (Taipei, TW)
14:00P4082Clinical characteristics of patients with lone atrial fibrillation in Japan: from the Fushimi AF registry.Masaharu AKAO (Kyoto, JP)
14:00P4083Elevated levels of cardiac troponin T in patients with permanent atrial fibrillation without ischemic heart diseaseSara Reinvik ULIMOEN (Rud, NO)
14:00P4084Prognostic significance of in-hospital atrial fibrillation across the whole spectrum of acute coronary syndromesFabio VAGNARELLI (Bologna, IT)
14:00P4085Renal impairment and stroke risk assessment in patients with atrial fibrillation.Laurent FAUCHIER (Tours, FR)
14:00P4086(W)Long-term course after atrial fibrillation ablation in patients with impaired left ventricular systolic function. The importance of rhythm and rate control. 
14:00P4087MIR146A polymorphisms predict cardiovascular risk in atrial fibrillation patients.Vanessa ROLDAN-SCHILLING (Murcia, ES)
14:00P4088Prevalence of atrial fibrillation in patients with sarcoidosisDeepak PATTANSHETTY (Cleveland, US)
14:00P4089Rhythm versus rate control therapy and subsequent stroke /thromboembolic events in patients with atrial fibrillationLaurent FAUCHIER (Tours, FR)
14:00P4090(W)Digoxin does not influence outcome in patients with permanent atrial fibrillation: data of the RACE II study 
14:00P4091Obesity surgery and incidence of atrial fibrillationShabbar JAMALY (Gothenburg, SE)
14:00P4092Predicting silent cerebral microischemia in patients with non-valvular atrial fibrillation and structurally normal hearts: the CHADS2, CHA2DS2-VASc and -R scoresTatjana POTPARA (Belgrade, RS)
14:00P4093Outcomes in patients with atrial fibrillation undergoing coronary artery stenting with a low-moderate CHA2DS2VASc score: do they need anticoagulation?Maria MUTUBERRIA URDANIZ (Barcelona, ES)
14:00P4094New onset atrial fibrillation and long-term risk of heart failure in the general population: the Rotterdam studyMaarten J G LEENING (Rotterdam, NL)
14:00P4095Usefulness of N-terminal pro-B-type natriuretic peptide levels for stroke prediction in anticoagulated patients with atrial fibrillation.Vanessa ROLDAN-SCHILLING (Murcia, ES)
14:00P4096Obese heart syndrome: Epicardial adiposity in subtypes of atrial fibrillationKudret AYTEMIR (Ankara, TR)
14:00P4097(W)Amiodarone is associated with higher mortality rates in patients with atrial fibrillation and a low CHA2DS2Vasc score 
14:00P4098Septal assessed mitral annular plane systolic excursion a determinant of atrial fibrillation in patients with hypertrophic cardiomyopathyChristina DOESCH (Mannheim, DE)
14:00P4099Detection of paroxysmal atrial fibrillation by an implantable subcutaneous holter in patients with non-lacunar cryptogenic ischemic strokeMaria SANDIN (Valladolid, ES)
14:00P4100Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care systemTomas FORSLUND (Stockholm, SE)
14:00P4101Silent cerebral lesions in patients with non-valvular atrial fibrillation and structurally normal hearts Tatjana POTPARA (Belgrade, RS)
14:00P4102Long-term all-cause mortality and cardiovascular risk in 26 488 patients hospitalized with incident atrial fibrillation and no other medical diagnosis Dritan POCI (Orebro, SE)
14:00P4103Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation Tze-Fan CHAO (Taipei, TW)
14:00P4104Atrial fibrillation types predict the development of contrast-induced nephropathy in patients with acute myocardial infarction treated invasivelyTomasz PODOLECKI (Zabrze, PL)
14:00P4105Exercise intolerance in patients on dronedarone. What is the underlying mechanism?Samir SAID (Magdeburg, DE)
14:00P4106changes of endothelial function in hypertensive patients with persistent atrial fibrillation.Aida TARZIMANOVA (Moscow, RU)
14:00P4107Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgeryIoannis SKOULARIGIS (Larissa, GR)
14:00P4108Relationship of circulating coagulation/fibrinolysis and endothelium biomarkers with CHA2DS2-VASc scores in arrhythmia patientsMitsuhiro FUKATA (Fukuoka, JP)
14:00P4109Effect of peripheral ischemic preconditioning on platelet activation related ablation of atrial fibrillationAlessandra STAZI (Palestrina, IT)
14:00P4110Epicardial fat is associated with the level of endothelial dysfunction in patients with atrial fibrillationNicolas GIRERD (Nancy, FR)
14:00P4111Inhibition of aldosteronsynthase regulates miR-21 during atrial fibrillation in miceOliver ADAM (Homburg/Saar, DE)
14:00P4112The mineralocorticoid receptor promotes pro-fibrotic remodeling in atrial fibrillationDaniel LAVALL (Homburg, DE)
14:00P4113The effects of ranolazine on paroxysmal atrial fibrillation in patients with coronary artery diseaseDionyssios LEFTHERIOTIS (Athens, GR)
14:00P4114Safety in rate control medication in patients with atrial fibrillation: a nationwide study.Morten Winther HVIDTFELDT (Copenhagen N, DK)
14:00P4115Ranolazine plus amiodarone for conversion of paroxysmal atrial fibrillation Konstantinos KOSKINAS (Thessaloniki, GR)
14:00P4116Patients with persistent atrial fibrillation profit most from atrial remodelling after re-establishment of sinus rhythm after pulmonary vein isolation.Ernst WELLNHOFER (Berlin, DE)
14:00P4117Predicting onset of atrial fibrillation based on ECG P-wave duration: results from the Copenhagen ECG StudyJonas Bille NIELSEN (Copenhaegn, DK)
14:00P4118The long term changes in left atrial phasic function after successful ablation of paroxysmal atrial fibrillation.Mina KIM (Seoul, KR)
14:00P4119Prevalence of previous history of atrial fibrillation in patients referred for ablation of atrial flutter Beatrice BREMBILLA-PERROT (Vandoeuvre Les Nancy, FR)
14:00P4120Long term follow up after catheter ablation of persistent atrial fibrillation using the "stepwise approach" with the attempted endpoint of atrial fibrillation terminationDoreen SCHREIBER (Hamburg, DE)
14:00P4121Gold tip ablation facilitates acute pulmonary vein isolation. A prospective randomized pilot studyBoris SCHMIDT (Frankfurt, DE)
14:00P4122Identifying a single p-wave during a cardiac cycle to reduce inappropriate detection of atrial tachyarrhythmia episodes in an implantable loop recorder Shantanu SARKAR (Moundsview, US)
14:00P4123Gastroparesis: an under-recognized complication after atrial fibrillation catheter ablation procedureManuel GARCIA DE YEBENES CASTRO (Pamplona, ES)
14:00P4124Enhanced efficiency of a novel porous irrigated RF ablation catheter for pulmonary vein isolationJuergen ALLGEIER (Bad Krozingen, DE)
14:00P4125Propensity-score-matched comparison of cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillationSven KNECHT (Basel, CH)
14:00P4126ECG and echocardiographic changes after linear ablation at the superior left atrial septumMichele BRUNELLI (Bad Berka, DE)
14:00P4127Does PV isolation with a multipolar ablation catheter influence the incidence of PV stenosis in patients with paroxysmal or persistent AF?Stefan G SPITZER (Dresden, DE)